South State Corp Astrazeneca PLC Transaction History

South State Corp

$2.12 Billion
Q3 2025

A detailed history of South State Corp transactions in Astrazeneca PLC stock. As of the latest transaction made, South State Corp holds 61,445 shares of AZN stock, worth $5.49 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

61,445

Previous 63,350 3.01%

Holding current value

$5.49 Million

Previous $4.43 Million 6.51%

% of portfolio

0.22%

Previous 0.2%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 05, 2025	SELL	$68.72 - $82.11 $130,911 - $156,419	-1,905 Reduced 3.01%	61,445 $4.71 Million
Q2 2025 Aug 06, 2025	BUY	$64.87 - $75.0 $1,556 - $1,800	24 Added 0.04%	63,350 $4.43 Million
Q1 2025 May 12, 2025	BUY	$65.37 - $77.96 $37,064 - $44,203	567 Added 0.9%	63,326 $4.65 Million
Q4 2024 Feb 10, 2025	SELL	$63.2 - $79.58 $125,641 - $158,205	-1,988 Reduced 3.07%	62,759 $4.11 Million
Q3 2024 Nov 08, 2024	BUY	$76.67 - $87.62 $78,586 - $89,810	1,025 Added 1.61%	64,747 $5.05 Million

Q2 2024 Aug 02, 2024	SELL	$66.81 - $80.83 $17,838 - $21,581	-267 Reduced 0.42%	63,722 $4.97 Million
Q1 2024 May 06, 2024	BUY	$61.03 - $69.57 $104,239 - $118,825	1,708 Added 2.74%	63,989 $4.34 Million
Q4 2023 Feb 06, 2024	SELL	$61.89 - $69.28 $14,049 - $15,726	-227 Reduced 0.36%	62,281 $4.19 Million
Q3 2023 Nov 07, 2023	SELL	$64.85 - $71.7 $11,867 - $13,121	-183 Reduced 0.29%	62,508 $4.23 Million
Q2 2023 Aug 08, 2023	SELL	$69.91 - $75.81 $35,234 - $38,208	-504 Reduced 0.8%	62,691 $4.49 Million
Q1 2023 May 08, 2023	SELL	$63.15 - $71.6 $55,445 - $62,864	-878 Reduced 1.37%	63,195 $4.39 Million
Q4 2022 Feb 10, 2023	BUY	$54.21 - $70.44 $28,351 - $36,840	523 Added 0.82%	64,073 $4.34 Million
Q3 2022 Nov 07, 2022	SELL	$53.02 - $135.75 $202,218 - $517,750	-3,814 Reduced 5.66%	63,550 $3.49 Million
Q2 2022 Aug 05, 2022	SELL	$59.26 - $71.14 $240,417 - $288,614	-4,057 Reduced 5.68%	67,364 $4.45 Million
Q1 2022 May 06, 2022	BUY	$55.72 - $67.12 $25,352 - $30,539	455 Added 0.64%	71,421 $4.74 Million
Q4 2021 Feb 11, 2022	SELL	$54.02 - $63.83 $172,755 - $204,128	-3,198 Reduced 4.31%	70,966 $4.13 Million
Q3 2021 Nov 10, 2021	BUY	$55.56 - $60.79 $21,390 - $23,404	385 Added 0.52%	74,164 $4.45 Million
Q2 2021 Aug 10, 2021	SELL	$48.42 - $60.18 $75,970 - $94,422	-1,569 Reduced 2.08%	73,779 $4.42 Million
Q1 2021 May 12, 2021	SELL	$47.16 - $54.44 $105,166 - $121,401	-2,230 Reduced 2.87%	75,348 $3.75 Million
Q4 2020 Feb 10, 2021	SELL	$48.52 - $58.02 $237,165 - $283,601	-4,888 Reduced 5.93%	77,578 $3.88 Million
Q3 2020 Nov 10, 2020	BUY	$53.07 - $61.1 $266,464 - $306,783	5,021 Added 6.48%	82,466 $4.52 Million
Q2 2020 Aug 11, 2020	BUY	$43.1 - $55.31 $517,674 - $664,328	12,011 Added 18.36%	77,445 $4.1 Million
Q1 2020 May 04, 2020	BUY	$37.79 - $51.33 $440,858 - $598,815	11,666 Added 21.7%	65,434 $2.92 Million
Q4 2019 Feb 05, 2020	BUY	$42.46 - $50.46 $174,298 - $207,138	4,105 Added 8.27%	53,768 $2.68 Million
Q3 2019 Nov 08, 2019	SELL	$40.12 - $45.47 $63,349 - $71,797	-1,579 Reduced 3.08%	49,663 $2.21 Million
Q2 2019 Aug 13, 2019	BUY	$37.28 - $41.68 $10,736 - $12,003	288 Added 0.57%	51,242 $2.12 Million
Q1 2019 May 15, 2019	BUY	$35.49 - $43.02 $105,405 - $127,769	2,970 Added 6.19%	50,954 $2.06 Million
Q4 2018 Feb 11, 2019	SELL	$36.86 - $41.49 $2.03 Million - $2.29 Million	-55,077 Reduced 53.44%	47,984 $1.82 Million
Q3 2018 Nov 08, 2018	BUY	$34.76 - $39.72 $301,299 - $344,292	8,668 Added 9.18%	103,061 $4.08 Million
Q2 2018 Aug 03, 2018	BUY	$34.55 - $37.05 $995,247 - $1.07 Million	28,806 Added 43.92%	94,393 $3.31 Million
Q1 2018 May 11, 2018	BUY	$32.97 - $36.63 $2.16 Million - $2.4 Million	65,587 New	65,587 $2.29 Million

Others Institutions Holding AZN

# of Institutions

1,499

Shares Held

500M

Call Options Held

5.59M

Put Options Held

3.18M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of South State Corp, based on Form 13F filings with the SEC.

News

Stay updated on South State Corp with notifications on news.

Account